K. C.

A Review on Screen, Shield, Stop: Halting Hereditary Cancer through Genomic Surveillance and Crispr – Cas9

Hereditary cancers account for approximately 5–10% of all cancer cases and arise due to inherited pathogenic variants in cancer susceptibility genes. Advances in genomic medicine have transformed the early identification of individuals at high risk, enabling timely surveillance, preventive interventions, and personaliz...